It is also being investigated for cognitive benefits and improved metabolic function in experimental settings
How do you figure out what is actually going on with my gut
Stop-and-switch decisions should be made with a clinician, especially when other glucose-lowering medicines are involved
And just because something is being used off-label from what the FDA approved doesn't mean we can't use it
Incretins help coordinate post-meal metabolic responses by: Stimulating glucose-dependent insulin secretion Suppressing glucagon release Slowing gastric emptying to prolong satiety (10) Together, these effects reduce appetite, stabilize blood sugar levels, and decrease cravingskey drivers of weight loss and improved metabolic control in insulin-resistant states (11)
It will come down to developing a strategy, then choosing what we think are the right targets, designing stable molecules, running the studies, and having the discipline to stop if its not working